Last reviewed · How we verify
Treatment of Pediculosis (Head Lice) in Senegal (IVERAZITH)
This is a prospective single-arm interventional study evaluating Therapeutic efficacy of a combination of two pharmaceutical drugs, Azithromycin (AZIT) and Ivermectin (IVER) administered orally in the treatment of head lice infestations. In case of persistence of lice and / or nits on day 7, a second oral administration of combination Azithromycin + Ivermectin will be considered. The duration of the study period is 4 months, ie 1 month and ½ of inclusion and 2 months and ½ feedback. There will be a site initiation visit "site initiation visit" before inclusions at D-7, two monitoring visits and a closing visit "close out visit" at the end of the follow-up at 4 months.
Details
| Lead sponsor | Institut de Recherche pour le Developpement |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 450 |
| Start date | Wed Jul 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sun Feb 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Pediculoses
Interventions
- Ivermectin Oral Product
Countries
Senegal